[go: up one dir, main page]

NO964487D0 - Fremgangsmåte for diastereoselektiv syntese av nukleosidanaloger - Google Patents

Fremgangsmåte for diastereoselektiv syntese av nukleosidanaloger

Info

Publication number
NO964487D0
NO964487D0 NO964487A NO964487A NO964487D0 NO 964487 D0 NO964487 D0 NO 964487D0 NO 964487 A NO964487 A NO 964487A NO 964487 A NO964487 A NO 964487A NO 964487 D0 NO964487 D0 NO 964487D0
Authority
NO
Norway
Prior art keywords
nucleoside analogs
diastereoselective synthesis
diastereoselective
synthesis
nucleoside
Prior art date
Application number
NO964487A
Other languages
English (en)
Other versions
NO964487L (no
NO307179B1 (no
Inventor
Michael David Goodyear
P Owen Dwyer
Malcolm Leithead Hill
Andrew Jonathan Whitehead
Roy Hornby
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO964487D0 publication Critical patent/NO964487D0/no
Publication of NO964487L publication Critical patent/NO964487L/no
Publication of NO307179B1 publication Critical patent/NO307179B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
NO964487A 1994-04-23 1996-10-22 Stereoselektiv fremgangsmåte for fremstilling av nukleosidanaloger og salicylatsalt derav NO307179B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues

Publications (3)

Publication Number Publication Date
NO964487D0 true NO964487D0 (no) 1996-10-22
NO964487L NO964487L (no) 1996-12-17
NO307179B1 NO307179B1 (no) 2000-02-21

Family

ID=27267157

Family Applications (2)

Application Number Title Priority Date Filing Date
NO964487A NO307179B1 (no) 1994-04-23 1996-10-22 Stereoselektiv fremgangsmåte for fremstilling av nukleosidanaloger og salicylatsalt derav
NO19995646A NO313096B1 (no) 1994-04-23 1999-11-17 Fremgangsmåte for å öke utbyttet av nukleosidanaloger

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19995646A NO313096B1 (no) 1994-04-23 1999-11-17 Fremgangsmåte for å öke utbyttet av nukleosidanaloger

Country Status (29)

Country Link
US (2) US6051709A (no)
EP (1) EP0757684B1 (no)
JP (2) JP4056558B2 (no)
KR (1) KR100241842B1 (no)
CN (2) CN1151146C (no)
AP (1) AP704A (no)
AT (1) ATE181326T1 (no)
AU (1) AU696612B2 (no)
BG (1) BG62810B1 (no)
BR (1) BR9507499A (no)
CZ (1) CZ293827B6 (no)
DE (1) DE69510347T2 (no)
DK (1) DK0757684T3 (no)
EE (1) EE03442B1 (no)
ES (1) ES2133769T3 (no)
FI (1) FI120401B (no)
GR (1) GR3031043T3 (no)
HU (1) HU218044B (no)
IL (1) IL113432A (no)
IS (1) IS1844B (no)
NO (2) NO307179B1 (no)
NZ (1) NZ285396A (no)
PL (1) PL180090B1 (no)
RO (2) RO117916B1 (no)
RU (1) RU2158736C2 (no)
SK (1) SK281327B6 (no)
TW (1) TW487704B (no)
UA (1) UA43362C2 (no)
WO (1) WO1995029174A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
CA2203262A1 (en) * 1994-10-22 1996-05-02 Byeong Seon Jeong Nucleoside derivatives and process for preparing thereof
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
ATE282034T1 (de) * 1998-08-12 2004-11-15 Gilead Sciences Inc Verfahren zur herstellung von 1,3- oxathiolannukleoside
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
ATE383355T1 (de) 2001-03-01 2008-01-15 Abbott Lab Polymorph und andere kristallinische formen von zusammen-ftc
CA2351049C (en) 2001-06-18 2007-03-13 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
WO2009037538A2 (en) * 2007-09-17 2009-03-26 Aurobindo Pharma Ltd Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
WO2009069011A1 (en) 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process for the preparation of substituted 1,3-oxathiolanes
AU2008331167A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
AU2008331168A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Crystalline form I of lamivudine and its preparation
WO2009084033A2 (en) * 2007-12-07 2009-07-09 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
DK2488516T3 (en) 2009-10-14 2015-05-26 Mylan Lab Ltd Method of producing lamivudine and novel salts in the preparation thereof
SMT201800290T1 (it) 2010-01-27 2018-07-17 Viiv Healthcare Co Terapia antivirale
WO2011095987A1 (en) 2010-02-03 2011-08-11 Matrix Laboratories Ltd. Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
WO2011107920A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited A process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
WO2012137227A2 (en) 2011-04-08 2012-10-11 Laurus Labs Private Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
DE69233014T2 (de) * 1989-02-08 2004-01-08 Biochem Pharma Inc., Laval Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
EP0513917B2 (en) 1991-05-16 2001-03-07 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
PL180090B1 (pl) 2000-12-29
CN1290841C (zh) 2006-12-20
HU9602925D0 (en) 1996-12-30
RO118714B1 (ro) 2003-09-30
NO995646D0 (no) 1999-11-17
AP704A (en) 1998-12-04
GR3031043T3 (en) 1999-12-31
HK1004221A1 (en) 1998-11-20
DK0757684T3 (da) 2000-01-17
US6051709A (en) 2000-04-18
CN1149871A (zh) 1997-05-14
HU218044B (hu) 2000-05-28
EP0757684A1 (en) 1997-02-12
KR100241842B1 (ko) 2000-03-02
NZ285396A (en) 1998-10-28
FI964251L (fi) 1996-10-22
ES2133769T3 (es) 1999-09-16
NO313096B1 (no) 2002-08-12
EE03442B1 (et) 2001-06-15
IL113432A0 (en) 1995-07-31
SK281327B6 (sk) 2001-02-12
IS4366A (is) 1996-09-27
CZ293827B6 (cs) 2004-08-18
RO117916B1 (ro) 2002-09-30
TW487704B (en) 2002-05-21
UA43362C2 (uk) 2001-12-17
AP9600871A0 (en) 1996-10-31
BR9507499A (pt) 1997-09-23
CN1500782A (zh) 2004-06-02
CZ309696A3 (en) 1997-04-16
JPH10502615A (ja) 1998-03-10
HUT76296A (en) 1997-07-28
DE69510347D1 (de) 1999-07-22
JP4056558B2 (ja) 2008-03-05
NO964487L (no) 1996-12-17
BG62810B1 (bg) 2000-08-31
AU696612B2 (en) 1998-09-17
DE69510347T2 (de) 1999-11-18
BG100916A (en) 1997-07-31
NO307179B1 (no) 2000-02-21
AU2447195A (en) 1995-11-16
EE9600134A (et) 1997-04-15
PL316904A1 (en) 1997-02-17
WO1995029174A1 (en) 1995-11-02
EP0757684B1 (en) 1999-06-16
US6329522B1 (en) 2001-12-11
JP2007217425A (ja) 2007-08-30
ATE181326T1 (de) 1999-07-15
NO995646L (no) 1999-11-17
FI964251A0 (fi) 1996-10-22
SK135596A3 (en) 1997-07-09
IS1844B (is) 2003-01-30
IL113432A (en) 2000-11-21
CN1151146C (zh) 2004-05-26
RU2158736C2 (ru) 2000-11-10
FI120401B (fi) 2009-10-15

Similar Documents

Publication Publication Date Title
NO964487D0 (no) Fremgangsmåte for diastereoselektiv syntese av nukleosidanaloger
NO982624L (no) FremgangsmÕte for syntese av benzimidazolforbindelse
FI910263L (fi) Menetelmä valmistaa pimobendaanin oraalisia lääkeainemuotoja
FI971784A0 (fi) Apolipoproteiini B-synteesin estäjiä
DK0843672T3 (da) Enkeltreaktorsyntese af 2-oxazolidinonderivater
FI973591A0 (fi) Nya syntetiserade kryptofysiner
EE9700093A (et) Apolipoproteiin-B sünteesi inhiibitorid
NO20001387L (no) FremgangsmÕte for syntese av kinolinderivater
FI915514A7 (fi) Atsiinien synteesimenetelmä
NO943652D0 (no) Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner
NO20002935D0 (no) FremgangsmÕte for separering av indre lineære olefiner fra indre forgrenede olefiner
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
NO20001896L (no) FremgangsmÕte for syntese av klorpurinmellomprodukter
BR9708718A (pt) Sínteses de aminas substituídas
FI951350A0 (fi) Menetelmä substituoitujen imisadsoliyhdisteiden käyttökelpoisten välituotteiden syntetisoimiseksi
FI952142A7 (fi) Parannettu suurtuotantomenetelmä atsapironin synteesiä varten
EE04007B1 (et) Meetod kristalliliste ainete puhastamiseks
NO975384D0 (no) Fremgangsmåte for syntese av deoksypyridinolin
ZA953235B (en) Process for the diastereoselective synthesis of nucleoside analogues
SI0757684T1 (en) Process for the diastereoselective synthesis of nucleoside analogues
FI973052A0 (fi) Atsiinien synteesimenetelmä
NO963831D0 (no) Syntese av prototyper for renin-inhibitorer
FI102279B1 (fi) Välituotteita nukleosidien diastereoselektiivisiin synteesimenetelmiin
UA25728A (uk) Спосіб одержаhhя сорбеhту для очистки меляси

Legal Events

Date Code Title Description
MK1K Patent expired